Ceftazidime for Injection
Formulation (FDF) · for Injection · 0.5g; 1.0g; 1.5g; 2.0g; 2.5g
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Ceftazidime for Injection
- Dosage Form
- for Injection
- Strength
- 0.5g; 1.0g; 1.5g; 2.0g; 2.5g
- Therapy Area
- Infectious Diseases
- Indication
- Sepsis; Lower respiratory tract infection; Intra-abdominal infection; Biliary tract infection; Complicated urinary tract infection; Skin and soft tissue infection; Opportunistic infection; Nosocomial infection; Central nervous system infection
- Current Status
- Official FDF licensing catalog (UB251)
- GMP Certification
- CN - NMPA; JP - PMDA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
Japan
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price